Literature DB >> 8693698

Quantitative capillary reversed passive latex agglutination test for C-reactive protein (CRP) in the dog.

K Tagata1, S Yokoyama, T Ginbo, M Honda, T Okimura, M Odakura, M Nomura, S Yamamoto.   

Abstract

A capillary reversed passive latex agglutination test (capillary RPLA) was developed which allows quantification of serum C-reactive protein (CRP) within approximately 15 min. The logarithmic regression line (calibration curve) obtained after measuring each CRP concentration three times in twofold dilutions of a standard canine serum containing 222 micrograms/ml of CRP was y = 6.394 + 0.030x (r = 0.995). Capillary RPLA permitted quantification of CRP in the range 6.9-222 micrograms/ml. The coefficients of variation ranged from 10.28% to 12.40%. The recovery rates (percentage recovery) of CRP by capillary RPLA were within the range 87% to 106%. On measuring the CRP concentrations in sera from 78 dogs by capillary RPLA, single radial immunodiffusion (SRID) and enzyme-linked immunosorbent assay (ELISA), close correlations were demonstrated between SRID and capillary RPLA (y = 7.250 + 1.109x, r = 0.978), between SRID and ELISA (y = 3.042 + 1.059x, r = 0.967), and between capillary RPLA and ELISA (y = 1.778 + 0.929x, r = 0.962). Capillary RPLA may be considered useful as a routine biochemical technique for measurement of serum CRP concentration in the dog.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8693698     DOI: 10.1007/bf00346573

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  22 in total

1.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Acute phase response in the dog following surgical trauma.

Authors:  J G Conner; P D Eckersall; J Ferguson; T A Douglas
Journal:  Res Vet Sci       Date:  1988-07       Impact factor: 2.534

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Serum levels of interleukin-6 and acute phase responses.

Authors:  M W Nijsten; E R de Groot; H J ten Duis; H J Klasen; C E Hack; L A Aarden
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

5.  Isolation of canine C-reactive protein and characterization of its properties.

Authors:  S Yamamoto; K Tagata; H Nagahata; Y Ishikawa; M Morimatsu; M Naiki
Journal:  Vet Immunol Immunopathol       Date:  1992-01-31       Impact factor: 2.046

6.  Comparative study of serum amyloid A protein and C-reactive protein in disease.

Authors:  C P Maury
Journal:  Clin Sci (Lond)       Date:  1985-02       Impact factor: 6.124

7.  An immunoturbidimetric assay for canine C-reactive protein.

Authors:  P D Eckersall; J G Conner; J Harvie
Journal:  Vet Res Commun       Date:  1991       Impact factor: 2.459

8.  Determination of C-reactive protein in serum and plasma from healthy dogs and dogs with pneumonia by ELISA and slide reversed passive latex agglutination test.

Authors:  S Yamamoto; T Shida; T Okimura; K Otabe; M Honda; Y Ashida; E Furukawa; M Sarikaputi; M Naiki
Journal:  Vet Q       Date:  1994-07       Impact factor: 3.320

9.  Avidity of antibody and agglutinability of antibody-sensitized latex in latex agglutination test.

Authors:  S Yamamoto; K Tagata; Y Ishikawa; H Santsuka; M Yamada; M Morimatsu; M Naiki
Journal:  Vet Immunol Immunopathol       Date:  1993-04       Impact factor: 2.046

10.  Efficient preparation of monospecific anti-canine C-reactive protein serum and purification of canine C-reactive protein by affinity chromatography.

Authors:  S Yamamoto; N Abe; H Santsuka; T Shida; K Kishida; S Kuwajima; M Yamada; M Morimatsu; M Naiki
Journal:  Vet Immunol Immunopathol       Date:  1993-04       Impact factor: 2.046

View more
  2 in total

1.  Analytical and clinical validation of a time-resolved immunofluorometric assay (TR-IFMA) for canine C-reactive protein in serum.

Authors:  M D Parra; M Tuomola; J Cabezas-Herrera; J J Cerón
Journal:  Vet Res Commun       Date:  2006-02       Impact factor: 2.459

2.  Use of heterologous immunoassays for quantification of serum proteins: The case of canine C-reactive protein.

Authors:  Alberto Muñoz-Prieto; Asta Tvarijonaviciute; Damián Escribano; Silvia Martínez-Subiela; José J Cerón
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.